Alterola Biotech INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
10-K: Alterola Biotech Files 10-K Annual Report, Cites Going Concern Doubts Amidst Development Efforts
Alterola Biotech's annual report reveals ongoing financial challenges and a lack of revenue, while highlighting its focus on cannabinoid-based pharmaceutical development.